# Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients

> **NCT04414059** · — · COMPLETED · sponsor: **Elsan** · enrollment: 200 (actual)

## Conditions studied

- SARS-CoV 2
- Hospitalisation-Associated Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04414059
- **Lead sponsor:** Elsan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-10
- **Primary completion:** 2022-05-10
- **Final completion:** 2022-09-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04414059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04414059, "Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04414059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*